In conclusion, we conducted GEO-based large-sample differentially expressed gene and survival analyses and identified differences in HIF1A expression between CLL patients and normal controls as well as an effect on the survival of CLL patients. The gene discussed is HIF1A; the disease is B-cell chronic lymphocytic leukemia.